Basic Information
Basic information for HCG18-265-42aa
Peptide Name HCG18-265-42aa
Genome Position chr6:30292397-30292522[-]
Species Human
Peptide Sequence MFIAALLTVTKLGTVAHLTTVIPALWEAEVGGSPEVGSLRPA
Peptide Length 42
Unique No (HCG18-249-42aa,HCG18-250-42aa,HCG18-251-42aa,HCG18-252-42aa,HCG18-254-42aa,HCG18-255-42aa,HCG18-256-42aa,HCG18-257-42aa,HCG18-258-42aa,HCG18-259-42aa,HCG18-260-42aa,HCG18-261-42aa,HCG18-262-42aa,HCG18-263-42aa,HCG18-266-42aa,HCG18-267-42aa,HCG18-268-42aa)
Grand Average of Hydropathicity 0.8048
Relative Molecular Mass 5056.86
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000231074;HCG18
Transcript ID/Name ENST00000668974;HCG18-265
Transcript Length 6734
Coding Ability 0.4146
DNA Sequence Corresponding to Peptide ATGTTCATTGCAGCACTATTAACAGTAACAAAGCTGGGCACAGTGGCTCACCTCACGACTGTAATCCCAGCACTTTGGGAGGCTGAGGTAGGCGGATCACCTGAGGTCGGCAGTTTGAGACCAGCC
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :